Quality of life in reflux and dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD)

European Journal of Surgery, Supplement

Volumn 164, Issue 583, 1998, Pages 41-49

  Wiklund, Ingela K ^a   Junghard, Ola ^a   Grace, Eileen ^b   Talley, Nicholas J ^c   Kamm, Michael ^d   Van Zanten, Sander Veldhuyzen ^e   Paré, Pierre ^f   Chiba, Naoki ^g   Leddin, Desmond S ^h   Bigard, Marc André ⁱ   Colin, Raymond ^j   Schoenfeld, Philip ^k  

^a ASTRAZENECA R AND D   (Sweden)

^b Astra Pharma Inc   (Canada)

^c UNIVERSITY OF SYDNEY   (Australia)

^d ST MARK S HOSPITAL   (United Kingdom)

^e DALHOUSIE UNIVERSITY   (Canada)

^f LAVAL UNIVERSITY   (Canada)

^g Guelph General Hospital   (Canada)

^h QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

ⁱ Hopital Brabols   (France)

^j HÔPITAL CHARLES NICOLLE   (France)

^k WALTER REED ARMY MEDICAL CENTER   (United States)

more..

Author keywords

Dyspepsia; Gastroesophageal reflux disease; Psychometric documentation; Quality of life; Questionnaire

Indexed keywords

ADULT; AGED; ARTICLE; DYSPEPSIA; ENDOSCOPY; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; SCORING SYSTEM; TREATMENT OUTCOME; ADOLESCENT; GASTROINTESTINAL ENDOSCOPY; MIDDLE AGED; PILOT STUDY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DYSPEPSIA; ENDOSCOPY, GASTROINTESTINAL; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; SEX FACTORS;

EID: 0032216676     PISSN: 1102416X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Adami HO, Agenas I, Gustavsson S, et al. The clinical diagnosis of "gastritis". Aspects of demographic epidemiology and health care consumption based on a nationwide sample survey. Scand J Gastroenterol 1984; 19: 216-219.
2. Carmines EG, Zeller RA. Reliability and validity assessment In: Sullivan JL, Niemi RG, eds. Series Quantitative Applications in the Social Sciences. Sage University Papers, Beverly Hills/London/New Delhi, Sage Publications Inc, 1983.
3. Colin-Jones DG, Bloom B, Bodemar G, et al. Management of dyspepsia: Report of a working party. Lancet 1988; 1: 576-579.
4. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297-334.
5. Dent J. Long-term aims of treatment of reflux disease, and the role of non-drug measures. Digestion 1992; 51(Suppl 1): 30-34.
6. Dimenäs E, Glise H, Hallerbäck B, Hernqvist H, Svedlund J, Wiklund I. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol 1995; 30: 1046-1052.
7. Dimenäs E, Carlsson G, Glise H, Israelsson B, Wiklund I. Relevance of Norm Values as Part of the Documentation of Quality of Life Instruments for Use in Upper Gastrointestinal Disease. Scand J Gastroenterol 1996; 31 Suppl 221: 8-13.
8. Guyatt GH, Feeny DH, Patrick DL. Measuring health- related quality of life. Ann Intern Med 1993; 118: 622-629.
9. Hahn BA, Kirchdoerfer LJ, Fullerton S, Mayer E. Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life. Aliment Pharmacol Ther 1997; 11: 533-559.
10. Jones RH, Lydeard SE, Hobbs FD, et al. Dyspepsia in England and Scotland. Gut 1990; 31: 401-405.
11. Marquis P, Sapède C, Béchade D, et al. Development and psychometric validation of a disease specific quality of life questionnaire in gastro-oesophageal reflux. Qual Life Res 1995; 4: A457-458.
12. Mokken RJ Theory and Procedure of Scale Analysis. The Hague: Mouton, 1971.
13. Nyrén O, Lindberg G, Lindström E, Marké L-Å, Seensalu R. Economic costs of functional dyspepsia. Pharmacoeconomics 1992; 1: 312-324.
14. Shumaker S, Anderson R, Czajhowski S. Psychological tests and scales In: Spilker B, ed. Quality of life assessments in clinical trials. New York; Raven Press, 1990: 95-113.
15. Spechler SJ. Epidemiology and natural history of gastrooesophageal reflux disease. Digestion 1992; 51(suppl 1): 24-29.
16. Stewart AL, Greenfield S, Hays RD, et al. Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. JAMA 1989; 262: 907-913.
17. Talley NJ, Colin-Jones D, Koch KL, Koch M, Nyrén O, Stanghellini V. Functional dyspepsia: A classification with guidelines for diagnosis and management. Gastroenterol Int 1991; 4: 145-160.
18. Talley NJ, Holtmann G. Functional dyspepsia. Current treatment recommendations Drugs 1993; 45: 918-930.
19. Talley NJ, Weaver AL, Zinsmeister AR. Impact of functional dyspepsia on quality of life. Dig Dis Sci 1995; 40: 584-589.
20. Veldhuyzen van Zanten SJO, Cleary C, Talley NJ, et al. Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol 1996; 91: 660-673.
21. Ware Jr JE, Sherbourne CD. The MOS 36-item short- form health survey (SF-36): I. Conceptual framework and item selection. Med Care 1992; 30: 473-483.
22. Whitehead WE, Burnett CK, Cook EW, Taub E. Impact of irritable bowel syndrome on quality of life. Dig Dis Sci 1996; 41: 2248-2253.
23. Wiklund I, Herlitz J, Hjalmarson Å. Quality of life five years after myocardial infarction. Eur Hert J 1989; 10: 464-472.
24. Wiklund I, Butler-Wheelhouse P. Psychosocial factors and their role in symptomatic gastroesophageal reflux disease and functional dyspepsia. Scand J Gastroenterol 1996; 31(Suppl 220): 94-100.
25. Wiklund I, Glise H, Jerndal P, Carlsson J, Talley NJ. Does endoscopy have a positive impact on quality of life in dyspepsia? Gastrointest Endosc: in press.
26. Young T.L., Kirchdoerfer LJ, Osterhaus JT. A development and validation process for a disease-specific quality of life instrument. Drug Information Journal 1996; 30: 185-193.